Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.

Authors :: Fletcher RA
Herrington WG
Agarwal R
Mayne KJ
Arnott C
Jardine MJ
Mahaffey KW
Perkovic V
Staplin N
Wheeler DC
Chertow GM
Heerspink HJL
Neuen BL
Source :: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2024 Apr 16. Date of Electronic Publication: 2024 Apr 16.
Publication Year :: 2024
Publisher :: Ahead of Print
Abstract: Clinical Trial registry name and registration number: ClinicalTrials.gov Identifiers: NCT02065791 (CREDENCE), NCT03036150 (DAPA-CKD), NCT03594110 (EMPA-KIDNEY).<br /> (Copyright © 2024 by the American Society of Nephrology.)

Full Text Access

Tools